How we started

Mapreg was founded by Pr Etienne Baulieu, Dr Paul Robel, Dr Arlette Fellous and Dr Koichi Murakami in year 2000 when they discovered a completely novel path of action to treat neurological disorders.

• Etienne BAULIEU: MD, PhD, director of research at INSERM,
  • member of US and Fr academies of sciences,
  • 1989 Lasker Awardee
  • worldwide renown biochemist, expert in steroid hormones, conceived the RU486, revealed the properties of DHEA
• Paul ROBEL: MD, PhD, physiologist, has been working with Pr Baulieu for 50 y.
• Koïchi MURAKAMI: PhD, worked under Pr Baulieu supervision to purify the receptor of pregnenolone in brain
• Arlette FELLOUS: PhD, Director of research at CNRS, expert in microtubules and MAP2, identified the cerebral receptor of pregnenolone purified by Koïchi as the MAP2 protein.